IMI 1 GetReal closing meeting:
‘Delivering tools for real-world evidence development’
24 November, 2016, Brussels
Royal Flemish Academy of Belgium for Science and the Arts
GetReal aims to show how robust new methods of RWE collection and synthesis could be developed and considered for adoption earlier in pharmaceutical R&D and the healthcare decision making process. This will require companies, healthcare decision makers and other stakeholders to work together to generate a consensus on best practice in the use of RWE in regulatory and reimbursement decision-making.
Alternative evidence generating strategies will deliver more focused research in pharmaceutical R&D, and allow healthcare decision makers to be more certain when providing patients with access to new treatments.
This closing meeting will provide an update on the status of the project and what has been delivered.
November 24th 2016 Royal Flemish Academy of Belgium for Science and the Arts, Brussels
|9:30 – 10:30||Coffee and registration|
|10:30 – 10:35||Welcome by Rick Grobbee (UMCU) and Elaine Irving (GSK)|
|10:35 – 10:45||Real-world data and the IMI GetReal project
|10:45 – 12:25||Insights from GetReal: what has our collaboration delivered?
WP1: Working with stakeholders to explore alternative evidence generation: What have we learnt?
WP4: Evidence Synthesis and Predictive Modelling of Relative Effectiveness – Paving the Way to Best Practice
|12:25 – 12:30||Intro to demos of GetReal tools
|12:30 – 14:00||Lunch and demos/try-out of GetReal tools and outputs
|14:00 – 15:15||Panel discussion ‘Real-world data and drug development: how has GetReal helped?’
|15:15 – 15:35||Coffee Break|
|15:35 – 16:50||Panel discussion ‘Getting real about the future of real-world data research’
|16:50 – 17:00||Wrap up